CIRAX | GBLFX | CIRAX / GBLFX | |
Total Expense Ratio | 0.62 | 0.58 | 107% |
Annual Report Gross Expense Ratio | 0.62 | 0.58 | 107% |
Fund Existence | 23 years | 14 years | - |
Gain YTD | 13.061 | 10.242 | 128% |
Front Load | 4% | N/A | - |
Min. Initial Investment | 250 | 250 | 100% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 116B | 28.1B | 413% |
Annual Yield % from dividends | 2.97 | 2.27 | 131% |
Returns for 1 year | 15.72 | 7.99 | 197% |
Returns for 3 years | 35.30 | 31.12 | 113% |
Returns for 5 years | 56.07 | 28.01 | 200% |
Returns for 10 years | 83.78 | 45.82 | 183% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
LABU | 61.54 | 0.84 | +1.38% |
Direxion Daily S&P Biotech Bull 3X ETF | |||
XMAR | 38.38 | 0.06 | +0.17% |
FT Vest U.S. Eq Enh & ModBufETF-Mar | |||
PULS | 49.60 | 0.02 | +0.04% |
PGIM Ultra Short Bond ETF | |||
GJH | 9.34 | N/A | N/A |
Synthetic Fixed-Income Sec STRATS 2004-06 | |||
IBIF | 26.02 | -0.02 | -0.10% |
iShares iBonds Oct 2029 Term Tips ETF |